Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 4/20 | 0.35 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1631413 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MAPTPTGS1DPP4SLC1A2 | |
| Hydrochloric Acid SCHEMBL23462497 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPTPTGS1DPP4SLC1A2 | |
| Hydrochloric Acid SCHEMBL7379812 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPTPTGS1DPP4SLC1A2 | |
| SCHEMBL20960490 | 0.82 | PTGS1 (0.54) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 | |
| SCHEMBL9358019 | 0.81 | ALDH1A1 (0.48) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 | |
| SCHEMBL20738916 | 0.80 | DPP4 (0.38) | ALDH1A1MAPTPTGS1DPP4 | |
| SCHEMBL4956090 | 0.80 | PTGS1 (0.52) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 | |
| SCHEMBL5288950 | 0.80 | ALDH1A1 (0.52) | ALDH1A1MAPTPTGS1DPP4SLC1A2 | |
| SCHEMBL4851556 | 0.80 | PTGS1 (0.52) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 | |
| SCHEMBL28705428 | 0.80 | PTGS1 (0.52) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117062826-A | Antiinfective bicyclic peptide ligands | 拜斯科技术开发有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-116802190-A | Bicyclic peptide ligands specific for transferrin receptor 1 (TfR 1) | 拜斯科技术开发有限公司 | 2023-09-22 | — | — | CN | claimed |
| EP-3335720-A1 | C-DI-GMP BINDING PEPTIDES | Universität Basel (CH) | 2018-06-20 | — | — | EP | claimed |
| US-9376694-B2 | Method for preparing optically active amino acid using cosubstrate shuttling of transaminase | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2016-06-28 | — | — | US | claimed |
| US-20150284750-A1 | METHOD FOR PREPARING OPTICALLY ACTIVE AMINO ACID USING COSUBSTRATE SHUTTLING OF TRANSAMINASE | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2015-10-08 | — | — | US | claimed |
| CN-1578786-A | Linear basic compounds having NK-2 antagonistic activity and formulations thereof | MENARINI RICERCHE SPA (IT) | 2005-02-09 | — | — | CN | claimed |
| US-20040259930-A1 | Linear basic compounds having nk-2 antagonist activity and formulations thereof | MALESCI INSTITUTO FARMACOBIOLOGICO S.P.A. (IT) | 2004-12-23 | — | — | US | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| EP-0626941-A1 | PROCESS FOR THE PREPARATION OF $g(b),$g(b)-DIALKYL AND $g(b),$g(b),$g(b)-TRIALKYL $g(a)-AMINO ACIDS | THE ASSOCIATED OCTEL COMPANY LIMITED (GB) | 1994-12-07 | — | — | EP | claimed |
| WO-1993016032-A1 | PROCESS FOR THE PREPARATION OF β,β-DIALKYL AND β,β,β-TRIALKYL α-AMINO ACIDS | THE ASSOCIATED OCTEL COMPANY LIMITED (GB) | 1993-08-19 | — | — | WO | claimed |
| US-12630521-B2 | Arylamides and methods of use thereof | GENZYME CORPORATION (US) | 2026-05-19 | — | — | US | disclosed |
| US-12630498-B2 | Arylamides and methods of use thereof | GENZYME CORPORATION (US) | 2026-05-19 | — | — | US | disclosed |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | disclosed |
| EP-4684030-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-20250059171-A1 | ANTIVIRAL COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 2025-02-20 | — | — | US | disclosed |
| US-5516755-A | Antitumor and antibacterial peptide and methods of use | HARBOR BRANCH OCEANOGRAPHIC INSTITUTION, INC. (US) | 1996-05-14 | — | — | US | disclosed |
| WO-1996012499-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-05-02 | — | — | WO | disclosed |
| EP-0626941-A1 | PROCESS FOR THE PREPARATION OF $g(b),$g(b)-DIALKYL AND $g(b),$g(b),$g(b)-TRIALKYL $g(a)-AMINO ACIDS | THE ASSOCIATED OCTEL COMPANY LIMITED (GB) | 1994-12-07 | — | — | EP | disclosed |
| US-5336757-A | Antibacterial peptide and methods of use | HARBOR BRANCH OCEANOGRAPHIC INSTITUTION, INC. (US) | 1994-08-09 | — | — | US | disclosed |
| WO-1993016032-A1 | PROCESS FOR THE PREPARATION OF β,β-DIALKYL AND β,β,β-TRIALKYL α-AMINO ACIDS | THE ASSOCIATED OCTEL COMPANY LIMITED (GB) | 1993-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630521-B2 | Arylamides and methods of use thereof | CFTR, CLIC1, CLCN2 | ALDH1A1 905/4885MAPT 4872/4885PTGS1 3305/4885 |
| US-20040259930-A1 | Linear basic compounds having nk-2 antagonist activity and formulations thereof | BDKRB2, BDKRB1, TACR2 | ALDH1A1 2231/4885MAPT 4098/4885PTGS1 413/4885 |
| US-12630498-B2 | Arylamides and methods of use thereof | CFTR, CLIC1, CLCN2 | ALDH1A1 775/4885MAPT 4884/4885PTGS1 3165/4885 |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | CTH, VIP, CXCL10 | ALDH1A1 4815/4885MAPT 4663/4885PTGS1 3432/4885 |
| US-20250059171-A1 | ANTIVIRAL COMPOUNDS | ZC3HAV1, ACE, EIF2AK2 | ALDH1A1 2030/4885MAPT 2772/4885PTGS1 1592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.